Columbia University Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Columbia University Herbert Irving Comprehensive Cancer Center has participated in 11 clinical trials with 7 currently active.
Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, Colorectal Cancer.
Sponsors: Bicara Therapeutics, TScan Therapeutics, Inc., GlycoMimetics Incorporated.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Columbia University Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Columbia University Herbert Irving Comprehensive Cancer Center has 11 clinical trials on record, with 7 currently active. Their work covers Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, Colorectal Cancer.
Yes — Columbia University Herbert Irving Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.